StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.89−0.03 (-3.28%)

Close on Nov 17, 2026Market cap $50.03MP/E –Yield –

PDS Biotechnology ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

For fiscal 2020 it was -$14.89M.

Annual ebitda

PeriodPeriod endValueChange
FY2020Dec 31, 2020-$14.89M–
FY2019Dec 31, 2019-$21.03M–
FY2018Dec 31, 2018-$3.58M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q1 FY2020Mar 31, 2020-$4.03M–
Q1 FY2019Mar 31, 2019-$4.92M–

More PDS Biotechnology figures

See a number that looks wrong?